AC IMMUNE SA SF-02 (IMR) — Cash Flow-to-Debt Ratio
AC IMMUNE SA SF-02 (IMR) has a Cash Flow-to-Debt Ratio of -0.15x as of December 2025, meaning its operating cash flow of €-16.51 Million could theoretically repay 0% of its total liabilities (€109.37 Million) in one year. See IMR FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
AC IMMUNE SA SF-02 Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for AC IMMUNE SA SF-02 across 5 annual periods. Also explore AC IMMUNE SA SF-02 net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for AC IMMUNE SA SF-02 (2021–2025)
Year-by-year debt coverage analysis for AC IMMUNE SA SF-02. For market capitalisation and broader financial context, see how much is AC IMMUNE SA SF-02 worth.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.63x | €-69.26 Million | €109.37 Million | ▼ -214.1% |
| 2024 | 0.55x | €65.84 Million | €118.64 Million | ▲ +120.4% |
| 2023 | -2.72x | €-60.41 Million | €22.17 Million | ▲ +37.2% |
| 2022 | -4.34x | €-73.57 Million | €16.95 Million | ▼ -94.7% |
| 2021 | -2.23x | €-65.69 Million | €29.46 Million | — |